Literature DB >> 9202199

Growth inhibition by insulin-like growth factor (IGF) binding protein-3--what's IGF got to do with it?

M M Rechler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9202199     DOI： 10.1210/endo.138.7.5355

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  11 in total

1.  Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy.

Authors:  F Broglio; A Benso; E Arvat; G Aimaretti; C Gottero; R Granata; M F Boghen; M Bobbio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

Review 2.  What's new in the IGF-binding proteins?

Authors:  Steven A Rosenzweig
Journal:  Growth Horm IGF Res       Date:  2004-10       Impact factor: 2.372

3.  Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study.

Authors:  Graziano Onder; Rosa Liperoti; Andrea Russo; Ettore Capoluongo; Angelo Minucci; Paola Lulli; Matteo Cesari; Marcello Maggio; Roberto Bernabei; Francesco Landi
Journal:  Eur J Clin Pharmacol       Date:  2007-02-02       Impact factor: 2.953

Review 4.  Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer.

Authors:  Angelos K Sikalidis; Behzad Varamini
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

5.  Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3).

Authors:  R Granata; F Broglio; D Migliorino; S Cutrupi; G Baldanzi; M Sireno; A Fubini; A Grazian; E Ghigo; A Pucci
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

6.  Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?

Authors:  Jane Jijun Liu; Mihaela Druta; David Shibata; Domenico Coppola; Ivette Boler; Abul Elahi; Richard R Reich; Erin Siegel; Martine Extermann
Journal:  J Geriatr Oncol       Date:  2013-12-18       Impact factor: 3.599

7.  Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.

Authors:  Charles S Fuchs; Richard M Goldberg; Daniel J Sargent; Jeffrey A Meyerhardt; Brian M Wolpin; Erin M Green; Henry C Pitot; Michael Pollak
Journal:  Clin Cancer Res       Date:  2008-12-10       Impact factor: 12.531

8.  A distal regulatory region of the insulin-like growth factor binding protein-2 (IGFBP-2) gene interacts with the basic helix-loop-helix transcription factor, AP-4.

Authors:  L Badinga; S Song; R C Simmen; F A Simmen
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

9.  Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.

Authors:  B M Wolpin; D S Michaud; E L Giovannucci; E S Schernhammer; M J Stampfer; J E Manson; B B Cochrane; T E Rohan; J Ma; M N Pollak; C S Fuchs
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

10.  Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and pathologic Gleason score.

Authors:  Myong Kim; Jong Won Kim; Jong Keun Kim; Sang Mi Lee; Cheryn Song; In Gab Jeong; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.